Shandong Bailong Chuangyuan Bio-Tech Co Ltd
SSE:605016
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Shandong Bailong Chuangyuan Bio-Tech Co Ltd
Gross Profit
Shandong Bailong Chuangyuan Bio-Tech Co Ltd
Gross Profit Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Shandong Bailong Chuangyuan Bio-Tech Co Ltd
SSE:605016
|
Gross Profit
¥570.6m
|
CAGR 3-Years
36%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
|
Inner Mongolia Yili Industrial Group Co Ltd
SSE:600887
|
Gross Profit
¥39.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
3%
|
CAGR 10-Years
7%
|
|
|
Foshan Haitian Flavouring and Food Co Ltd
SSE:603288
|
Gross Profit
¥11.6B
|
CAGR 3-Years
8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
|
Yihai Kerry Arawana Holdings Co Ltd
SZSE:300999
|
Gross Profit
¥12.4B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
Muyuan Foods Co Ltd
SZSE:002714
|
Gross Profit
¥20.4B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
33%
|
|
|
Wens Foodstuff Group Co Ltd
SZSE:300498
|
Gross Profit
¥8.7B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-3%
|
|
Shandong Bailong Chuangyuan Bio-Tech Co Ltd
Glance View
Shandong Bailong Chuangyuan Bio-Tech Co Ltd is a CN-based company operating in Food Products industry. The company is headquartered in Dezhou, Shandong and currently employs 607 full-time employees. The company went IPO on 2021-04-21. Shandong Bailong Chuangyuan Bio-Tech Co Ltd is a China-based company mainly engaged in food additives. The firm's main businesses include prebiotic series products, mainly including fructooligosaccharides, isomalt oligosaccharides, galacto-oligosaccharides, xylo-oligosaccharides; dietary fiber series products, mainly including resistant dextrin and polydextrose; other starch sugar (alcohol) products, mainly including maltitol, fructose syrup, and maltose syrup; and healthy sweetener products, mainly for the research and development, production and sales of allulose. The firm's main products are widely used in food, dairy products, infant milk powder, functional beverages, health care products, medicine, animal nutrition and feed industries.
See Also
What is Shandong Bailong Chuangyuan Bio-Tech Co Ltd's Gross Profit?
Gross Profit
570.6m
CNY
Based on the financial report for Dec 31, 2025, Shandong Bailong Chuangyuan Bio-Tech Co Ltd's Gross Profit amounts to 570.6m CNY.
What is Shandong Bailong Chuangyuan Bio-Tech Co Ltd's Gross Profit growth rate?
Gross Profit CAGR 5Y
29%
Over the last year, the Gross Profit growth was 48%. The average annual Gross Profit growth rates for Shandong Bailong Chuangyuan Bio-Tech Co Ltd have been 36% over the past three years , 29% over the past five years .
